ciprofloxacin has been researched along with Severe Acute Respiratory Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Severe Acute Respiratory Syndrome: A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedl, C | 1 |
| Hackl, G | 1 |
| Schilcher, G | 1 |
| Rosenkranz, AR | 1 |
| Eller, K | 1 |
| Eller, P | 1 |
1 review available for ciprofloxacin and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ciprofloxacin; | 2017 |